Literature DB >> 19663554

Brain penetration effects of microelectrodes and deep brain stimulation leads in ventral intermediate nucleus stimulation for essential tremor.

Takashi Morishita1, Kelly D Foote, Samuel S Wu, Charles E Jacobson, Ramon L Rodriguez, Ihtsham U Haq, Mustafa S Siddiqui, Irene A Malaty, Christopher J Hass, Michael S Okun.   

Abstract

OBJECT: Microelectrode recording (MER) and macrostimulation (test stimulation) are used to refine the optimal deep brain stimulation (DBS) lead placement within the operative setting. It is well known that there can be a microlesion effect with microelectrode trajectories and DBS insertion. The aim of this study was to determine the impact of intraoperative MER and lead placement on tremor severity in a cohort of patients with essential tremor.
METHODS: Consecutive patients with essential tremor undergoing unilateral DBS (ventral intermediate nucleus stimulation) for medication-refractory tremor were evaluated. Tremor severity was measured at 5 time points utilizing a modified Tremor Rating Scale: 1) immediately before MER; 2) immediately after MER; 3) immediately after lead implantation; 4) 6 months after DBS implantation in the off-DBS condition; and 5) 6 months after implantation in the on-DBS condition. To investigate the impact of the MER and DBS lead placement, Wilcoxon signed-rank tests were applied to test changes in tremor severity scores over the surgical course. In addition, a generalized linear mixed model including factors that potentially influenced the impact of the microlesion was also used for analysis.
RESULTS: Nineteen patients were evaluated. Improvement was noted in the total modified Tremor Rating Scale, postural, and action tremor scores (p < 0.05) as a result of MER and DBS lead placement. The improvements observed following lead placement were similar in magnitude to what was observed in the chronically programmed clinic setting parameters at 6 months after lead implantation. Improvement in tremor severity was maintained over time even in the off-DBS condition at 6 months, which was supportive of a prolonged microlesion effect. The number of macrostimulation passes, the number of MER passes, and disease duration were not related to the change in tremor severity score over time.
CONCLUSIONS: Immediate improvement in postural and intention tremors may result from MER and DBS lead placement in patients undergoing DBS for essential tremor. This improvement could be a predictor of successful DBS lead placement at 6 months. Clinicians rating patients in the operating room should be aware of these effects and should consider using rating scales before and after lead placement to take these effects into account when evaluating outcome in and out of the operating room.

Entities:  

Mesh:

Year:  2010        PMID: 19663554     DOI: 10.3171/2009.7.JNS09150

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  17 in total

1.  Intraoperative acceleration measurements to quantify improvement in tremor during deep brain stimulation surgery.

Authors:  Ashesh Shah; Jérôme Coste; Jean-Jacques Lemaire; Ethan Taub; W M Michael Schüpbach; Claudio Pollo; Erik Schkommodau; Raphael Guzman; Simone Hemm-Ode
Journal:  Med Biol Eng Comput       Date:  2016-09-08       Impact factor: 2.602

Review 2.  Deep Brain Stimulation Emergencies: How the New Technologies Could Modify the Current Scenario.

Authors:  Giovanni Cossu; Mariachiara Sensi
Journal:  Curr Neurol Neurosci Rep       Date:  2017-07       Impact factor: 5.081

Review 3.  Deep brain stimulation: are astrocytes a key driver behind the scene?

Authors:  Albert J Fenoy; Laurent Goetz; Stéphan Chabardès; Ying Xia
Journal:  CNS Neurosci Ther       Date:  2014-01-24       Impact factor: 5.243

4.  Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression.

Authors:  Paul E Holtzheimer; Mary E Kelley; Robert E Gross; Megan M Filkowski; Steven J Garlow; Andrea Barrocas; Dylan Wint; Margaret C Craighead; Julie Kozarsky; Ronald Chismar; Jared L Moreines; Klaus Mewes; Patricio Riva Posse; David A Gutman; Helen S Mayberg
Journal:  Arch Gen Psychiatry       Date:  2012-01-02

5.  Steady or not following thalamic deep brain stimulation for essential tremor.

Authors:  Nelson Hwynn; Christopher J Hass; Pamela Zeilman; Janet Romrell; Yunfeng Dai; Sam S Wu; Kelly D Foote; S H Subramony; Genko Oyama; Frances Velez-Lago; Hubert H Fernandez; Andrew S Resnick; Irene A Malaty; Michael S Okun
Journal:  J Neurol       Date:  2011-03-27       Impact factor: 4.849

6.  The Functional Role of Thalamocortical Coupling in the Human Motor Network.

Authors:  Enrico Opri; Stephanie Cernera; Michael S Okun; Kelly D Foote; Aysegul Gunduz
Journal:  J Neurosci       Date:  2019-08-30       Impact factor: 6.167

7.  Deep brain stimulation in essential tremor: targets, technology, and a comprehensive review of clinical outcomes.

Authors:  Joshua K Wong; Christopher W Hess; Leonardo Almeida; Erik H Middlebrooks; Evangelos A Christou; Erin E Patrick; Aparna Wagle Shukla; Kelly D Foote; Michael S Okun
Journal:  Expert Rev Neurother       Date:  2020-03-02       Impact factor: 4.618

8.  Ventral Intermediate Nucleus Versus Zona Incerta Region Deep Brain Stimulation in Essential Tremor.

Authors:  Robert S Eisinger; Joshua Wong; Leonardo Almeida; Adolfo Ramirez-Zamora; Jackson N Cagle; Juan C Giugni; Bilal Ahmed; Alberto R Bona; Erin Monari; Aparna Wagle Shukla; Christopher W Hess; Justin D Hilliard; Kelly D Foote; Aysegul Gunduz; Michael S Okun; Daniel Martinez-Ramirez
Journal:  Mov Disord Clin Pract       Date:  2017-11-27

9.  Sustained Medication Reduction Following Unilateral VIM Thalamic Stimulation for Essential Tremor.

Authors:  Andrew S Resnick; Michael S Okun; Teresita Malapira; Donald Smith; Fernando L Vale; Kelly Sullivan; Amber Miller; Israt Jahan; Theresa Zesiewicz
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-04-06

10.  Delayed effect of craniotomy on experimental seizures in rats.

Authors:  Patrick A Forcelli; David Kalikhman; Karen Gale
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.